Skip to content

Journal · Immunology · Updated 21 November 2026

Immunologic Research

Read Immunologic Research articles on DeepDyve. No university library needed.

Immunologic Research covers basic and clinical immunology, from single-cell profiling of immune cells and macrophage signaling to vasculitis, reactive arthritis and cancer immunotherapy. Springer Nature publishes it. It was previously published as Survey of Immunologic Research. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Immunologic Research
Journal cover

Immunologic Research at a glance

Full title
Immunologic Research
Former title
Survey of Immunologic Research
Abbreviation (NLM)
Immunol Res
Publisher
Springer Nature
Print ISSN
0257-277X
Online ISSN (eISSN)
1559-0755
Current title since
1986
Subjects
Allergy and Immunology
Access model
Hybrid (22% free to read in 2026)

Ways to access Immunologic Research

22% of the articles Immunologic Research published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 22% of Immunologic Research articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
  3. Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
  4. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  5. A library. Your university, hospital or public library may subscribe to Immunologic Research. Check its journal list and whether it offers remote access.
  6. DeepDyve. Read Immunologic Research articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Impact factor and metrics

Immunologic Research’s 2025 Journal Impact Factor is 2.7, and its 5-year Impact Factor is 3.1.

2.7

Journal Impact Factor (2025)

3.1

5-year Impact Factor (2025)

8 days

Median time to first decision

Source: journal metrics on the Immunologic Research homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.

Recent Immunologic Research research worth reading

Published January to May 2026. Summaries describe what the authors report.

  1. LitStreamInfectious diseases · mRNA antibodies

    mRNA-Encoded antibodies as a next-generation therapeutic paradigm: a rapid and adaptive platform for the prevention and treatment of emerging and re-emerging infectious diseases — A critical review

    Singh reviews mRNA-encoded antibodies, which have the patient’s body express neutralizing antibodies, covering their mechanistic basis, lipid nanoparticle delivery, translational progress, safety considerations and preclinical work in models of Zika virus, Ebola virus and rabies.

    Singh · Immunologic Research, published online January 12, 2026 · DOI 10.1007/s12026-025-09737-z

  2. LitStreamOvarian cancer · CAR-NK cells

    Efficacy of chimeric antigen receptor natural killer cells in treatment of ovarian cancer. A meta-analysis of pre-clinical studies

    In a meta-analysis of fourteen pre-clinical in vivo experiments, Ahmed and colleagues report that CAR-NK cells significantly reduced tumor burden in ovarian cancer models compared with untreated controls and with unmodified or mock NK cells, and significantly prolonged survival.

    Ahmed et al. · Immunologic Research, published online February 20, 2026 · DOI 10.1007/s12026-026-09750-w

  3. LitStreamChronic inflammation · GLP-1

    GLP-1 and its derivatives are associated with the reduction of macrophage infiltration and inflammation in systemic chronic inflammatory diseases: a systematic review and meta-analysis of animal models

    In a systematic review and meta-analysis of 25 animal studies, Sha and colleagues report that GLP-1 and its derivatives reduced F4/80 mRNA and protein levels and several pro-inflammatory factors, while changes in M2 macrophage markers were not statistically significant.

    Sha et al. · Immunologic Research, published online March 17, 2026 · DOI 10.1007/s12026-026-09764-4

  4. Open accessSingle-cell sequencing · Immune cells

    Immune cell annotation in the single-cell studies: technologies, challenges, and integrative solutions

    The authors review why immune cells are hard to classify from single-cell RNA data alone, given mismatches between mRNA and protein levels, and how methods combining transcript and protein data, along with computational tools, can make annotation more reliable.

    George et al. · Immunologic Research, published online May 1, 2026 · DOI 10.1007/s12026-026-09780-4

  5. LitStreamVaccine design · Artificial intelligence

    An integrated AI-driven vaccine design process: a systematic review of workflows from generative design to translational prediction

    In a systematic review of 19 articles, Shafaati and colleagues report that transformer models and protein language models became dominant for epitope prediction and AlphaFold2 the standard for structural modeling, and they set out an integrated AI workflow from antigen discovery to clinical translation.

    Shafaati et al. · Immunologic Research, published online May 7, 2026 · DOI 10.1007/s12026-026-09763-5

See every Immunologic Research article on DeepDyve

Questions about Immunologic Research

How can I read Immunologic Research articles without a subscription?

22% of Immunologic Research articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Immunologic Research articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Immunologic Research?

Immunologic Research’s NLM (PubMed) abbreviation is Immunol Res.

What is the ISSN of Immunologic Research?

The print ISSN is 0257-277X and the online ISSN is 1559-0755.

What is the impact factor of Immunologic Research?

Immunologic Research’s Journal Impact Factor is 2.7 (2025), and its 5-year Impact Factor is 3.1, according to Springer Nature’s published metrics.

Is Immunologic Research open access?

Immunologic Research is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 33 of 147 Immunologic Research articles (22%) carry a Creative Commons license, per Crossref.

Immunologic Research articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.

Start reading Immunologic Research today

One month free, then less than $2 a day. Immunologic Research, plus millions of articles from thousands of journals.

Start free month

Like this: